Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
This study has been completed.
Study NCT00005972   Information provided by Cancer and Leukemia Group B
First Received: July 5, 2000   Last Updated: March 17, 2011   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)
Publications:
Rocha-Lima C, Herndon J 2nd, Lee M, Atkins J, Mauer A, Vokes E, Green M. Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902. Ann Oncol. 2007 Feb;18(2):331-7. Epub 2006 Oct 25.




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services